 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ProPhase Labs ( NASDAQ:PRPH ) Third Quarter 2023 Results Key Financial Results Revenue: US$8.37m (down 65% from 3Q...

ProPhase Labs Third Quarter 2023 Earnings: Misses Expectations

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ProPhase Labs, Inc. (NASDAQ: PRPH) ( ProPhase ) on behalf of the company's investors. Since May...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ProPhase Labs, Inc. (NASDAQ: PRPH) and Encourages Investors to Contact the Firm

Financial and Operational Highlights for the Third Quarter of 2023Related Stocks: PRPH...

ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

ProPhase Labs reports Q3 EPS (30c) vs 6c last year

Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024...

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating ProPhase Labs, Inc. (Nasdaq: PRPH) ( ProPhase or the Company ) on behalf of the Company's investors. The...

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into ProPhase Labs, Inc.; Urges ProPhase Stockholders to Contact Abbott Cooper Regarding Their Legal Rights

GARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on...

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

ProPhase Labs announces growth expectations for Pharmaloz

Pharmaloz plan is to build capacity with a goal to attain a revenue run-rate of $60 to $80 million by year-end 2024, with 20-25% pre-tax net margins and a goal for additional growth thereafter...

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

StockNews.com upgraded shares of ProPhase Labs (NASDAQ:PRPH  Free Report) from a sell rating to a hold rating in a research note released on Wednesday. Separately, HC Wainwright reiterated a...

ProPhase Labs (NASDAQ:PRPH) Upgraded by StockNews.com to "Hold"

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

Watchers	1,306
52-Wk Low	$4.05
52-Wk High	$10.86

Market Cap	$175.91M
Volume (M)	18,684.00
52-Wk High	$10.86
52-Wk Low	$4.05

PRPH ProPhase Labs Inc

About

Feed

News

Earnings

Fundamentals